ADAMTS-13 Clearance Major Pathogenic Mechanism in iTTP : vim

The findings suggest recombinant ADAMTS-13 may be a useful adjunct therapy to plasma exchange among patients who have thrombotic thrombocytopenic purpura (iTTP).

Related Keywords

, Adamts 13 , Pathogenic Mechanism , Adamts 13 Deficiency , Apex , Anti Adamts 13 Autoantibodies , Caplacizumab , Adamts 13 Clearance ,